P16INK4a and ProEx C immunostains facilitate differential diagnosis of hyperchromatic crowded groups in liquid-based papanicolaou tests with menstrual contamination

Acta Cytologica

Volumn 56, Issue 1, 2012, Pages 55-61

  Ge, Yimin ^a,b   Mody, Dina R ^a,b   Smith, Debora ^a   Anton, Rose ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cervical cancer; Hyperchromatic crowded group; Menstrual contamination; Papanicolaou tests; Squamous intraepithelial lesion

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ARTICLE; CELL DIFFERENTIATION; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MENSTRUATION; METAPLASIA; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PRIORITY JOURNAL; STROMA CELL; UTERINE CERVIX CARCINOMA;

EID: 84862912878     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000332978     Document Type: Article

References (25)

1. Chivukula M, Austin RM, Shidham VB: Evaluation and significance of hyperchro-matic crowded groups (HCG) in liquid-based paps. Cytojournal 2007; 4: 2.
2. Gupta N, Srinivasan R, Rajwanshi A: Func-tional biomarkers in cervical precancer: an overview. Diagn Cytopathol 2009; 38:618-623.
3. Risse EK, Ouwerkerk-Noordam E, Boon ME: Endometrial cells in liquid-based cervical cytology: a diagnostic pitfall solved by pre-paring cytohistology from the residual thin layer sample. Acta Cytol 2011; 55:327-333.
4. INK4a ) is superior to high-risk human papillomavirus testing in cervi-cal cytology for the prediction of underlying high-grade dysplasia. Cancer Cytopathol 2010; 118:146-156.
5. INK4a and pRb expression in cervi-cal squamous and glandular neoplasia. Hum Pathol 2004; 35: 689-696. (Pubitemid 38881079)
6. INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immuno-histochemical study with immunocyto-chemical correlations. Am J Surg Pathol 2003; 27: 187-193. (Pubitemid 36152227)
7. INK4a and high-risk human papillomavirus. Acta Obstet Gynecol Scand 2007; 86:94-98. (Pubitemid 46009533)
8. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, Duensing S, Sheets EE, Munger K, Crum CP: Ki-67, cyclin E, and p16INK4 are complimentary surrogate bio-markers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001; 25: 884-891. (Pubitemid 32594981)
9. Qiao X, Bhuiya TA, Spitzer M: Differentiat-ing high-grade cervical intraepithelial lesion from atrophy in postmenopausal women us-ing Ki-67, cyclin E, and p16 immunohisto-chemical analysis. J Low Genit Tract Dis 2005; 9: 100-107. (Pubitemid 40464079)
10. INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92:276-284. (Pubitemid 32225381)
11. Badr RE, Walts AE, Chung F, Bose S: BD Pro-Ex C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am J Surg Pathol 2008; 32:899-906.
12. Conesa-Zamora P, Domenech-Peris A, Orantes-Casado FJ, Ortiz-Reina S, Sahu-quillo-Frias L, Acosta-Ortega J, Garcia-Sola-no J, Perez-Guillermo M: Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study. Am J Clin Pathol 2009; 132: 378-390.
13. Conesa-Zamora P, Domenech-Peris A, Or-tiz-Reina S, Orantes-Casado FJ, Acosta-Ortega J, Garcia-Solano J, Perez-Guillermo M: Immunohistochemical evaluation of ProEx C in human papillomavirus-induced lesions of the cervix. J Clin Pathol 2009; 62: 159-162.
14. Halloush RA, Akpolat I, Jim Zhai Q, Schwartz MR, Mody DR: Comparison of ProEx C with p16INK4a and Ki-67 immuno-histochemical staining of cell blocks pre-pared from residual liquid-based cervico-vaginal material: a pilot study. Cancer 2008; 114:474-480.
15. Akpolat I, Smith DA, Ramzy I, Chirala M, Mody DR: The utility of p16INK4a and Ki-67 staining on cell blocks prepared from resid-ual thin-layer cervicovaginal material. Can-cer 2004; 102:142-149. (Pubitemid 38780598)
16. Keyhani-Rofagha S, Vesey-Shecket M: Diag-nostic value, feasibility, and validity of pre-paring cell blocks from fluid-based gyneco-logic cytology specimens. Cancer 2002; 96: 204-209. (Pubitemid 34920136)
17. Yang GC, Wan LS, Papellas J, Waisman J: Compact cell blocks. Use for body fluids, fine needle aspirations and endometrial brush biopsies. Acta Cytol 1998; 42:703-706. (Pubitemid 28274781)
18. Narine N, Rana DN, McVey RJ, Fitzmaurice R: Ancillary testing in liquid based cytology to distinguish cervical glandular neoplasia from tuboendometrial metaplasia in a young woman. Diagn Cytopathol 2010; 38:828-832.
19. Demay RM: Hyperchromatic crowded groups: pitfalls in pap smear diagnosis. Am J Clin Pathol 2000; 114(suppl):S36-S43.
20. INK4A immunostaining in cytological and histo-logical specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 2009; 35: 210-220.
21. Kong CS, Beck AH, Longacre TA: A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical ade-nocarcinomas. Am J Surg Pathol 2010; 34: 915-926.
22. INK4a expres-sion in basal-like breast carcinoma. Int J Clin Exp Pathol 2010; 3:600-607.
23. INK4A expression in human breast cancer. Am J Pathol 1996; 149:15-20. (Pubitemid 26230973)
24. Horree N, Heintz AP, Sie-Go DM, van Diest PJ: p16 is consistently expressed in endome-trial tubal metaplasia. Cell Oncol 2007; 29: 37-45. (Pubitemid 46535189)
25. Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH: Using biomark-ers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 2010; 34: 1077-1087.